Biotechnology Value Trading Fund OS LP, 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 267,603 shares at $4.02 ($1.1M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market purchase of $1.1M FPRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.02 | 2,397 | $10K | 0.9% |
| 2 | $4.02 | 18,729 | $75K | 7.0% |
| 3 | $4.02 | 18,729 | $75K | 7.0% |
| 4 | $4.02 | 113,874 | $458K | 42.6% |
| 5 | $4.02 | 113,874 | $458K | 42.6% |
| Total | $4.02 avg | 267,603 |
| $1.1M |
| 100% |
| Filing → |
| RPTX | BUY | 2023-11-03 | $5.6M | — | Filing → |
| OLMA | BUY | 2023-09-14 | $29.6M | — | Filing → |
| OLMA | BUY | 2022-06-14 | $1.6M | — | Filing → |